Kinderarztpraxis Leyental

The pediatric clinic at Kinderarztpraxis Leyental focuses on protecting children from serious bacterial threats such as meningococcal disease. Current studies aim to evaluate the safety and immune protection offered by a new pentavalent meningococcal vaccine across different age groups.

• Assessment of vaccine safety in infants, toddlers, and children
• Measurement of antibody response against multiple meningococcal serogroups
• Comparison with existing meningococcal vaccines
• Long‑term monitoring of immunogenicity in the pediatric population

Through these investigations, Kinderarztpraxis Leyental contributes to national immunization strategies and helps ensure that young patients receive effective protection against bacterial infections.

In the viral disease portfolio, the practice conducts a vaccine trial targeting respiratory syncytial virus (RSV) in infants and toddlers. The study seeks to demonstrate how the candidate RSV vaccine can prevent lower respiratory tract illness during the RSV season.

• Evaluation of vaccine efficacy in preventing RSV‑related lower respiratory illness
• Monitoring of safety outcomes in young children
• Analysis of immune response after the two‑dose schedule
• Impact assessment on RSV season disease burden

Results from this work aim to fill a critical gap in pediatric viral infection prevention and may shape future vaccination recommendations across Europe.